BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:The momentum of innate immune cell R and D is growing exponent
 ially to harness innate immune responses and promote gold-standard alloge
 neic therapies. Now is the time to gather this fledgling community and bu
 ild further collaboration at the centre of innovation: in Europe.\n\nThe 
 Innate Killer Summit Europe gathers 80+ key European Gamma Delta T\, NK\,
  iNKT\, neutrophil\, and macrophage developers in October to chase the ho
 ly grail of efficacious\, off-the-shelf\, solid tumour immunotherapies th
 rough effective and scalable engineering\, engager and combination strate
 gies that promote safe\, potent and persistent innate immune therapies fo
 llowing application.\n\nSeize your chance to network with innate immune t
 railblazers from the likes of Sanofi\, Takeda\, Lift Biosciences\, Mink T
 herapeutics\, Affimed\, Carisma Therapeutics\, Arovella Therapeutics and 
 receive 3-days of some of the best scientific and data driven case studie
 s that will help propel your innate immune therapy into the clinic and be
 yond.\n\nURLs:Tickets:&nbsp\;https://go.evvnt.com/1810491-2?pid=185Brochu
 re:&nbsp\;https://go.evvnt.com/1810491-3?pid=185\n\nPrices:Industry Prici
 ng - Conference + 2 Workshops: GBP 3097.00\,Industry Pricing - Conference
  + 1 Workshop: GBP 2648.00\,Industry Pricing - Conference Only: GBP 2199.
 00\,Academic Pricing - &nbsp\;Conference + 2 Workshops: GBP 2597.00\,Acad
 emic Pricing - Conference + 1 Workshop: GBP 2198.00\,Academic Pricing - C
 onference Only: GBP 1799.00\,Solution Providers - Conference + 2 Workshop
 s: GBP 4397.00\,Solution Providers - Conference + 1 Workshop: GBP 3748.00
 \,Solution Providers - Conference Only: GBP 3099.00\n\nSpeakers:&nbsp\;Al
 ex Blyth | Chief Executive Officer | Lift Biosciences\, Andre Kunert | Se
 nior Principal Scientist | Kiadis Pharma\, Anna-Karin Maltais | Chief Sci
 entific Officer | XNK Therapeutics\, Evren Alici | Head of Cell and Gene 
 Therapy Group | Karolinska Institutet\, François Gianelli &nbsp\;| Head o
 f Regulatory and Quality | TreeFrog Therapeutics\, Helgi Van De Velde | V
 ice President Head Hematologic Malignacies Strategies and Late Developmen
 t Malignan | Sanofi\, Joachim Koch | Vice President and Head Discovery Re
 search and Translational Immunology | Affimed\, Kate Rochlin | Chief Oper
 ating Officer | IN8Bio\, Keith Sutton | Director of Pre-Clinical Developm
 ent | Resolution Therapeutics\, Marc van Dijk | Chief Scientific Officer 
 | MiNK Therapeutics\, Michelle Morrow | Senior Vice President\, Head of R
 esearch | F-star Biotechnology Ltd.\, Nicolo Rigamonti | Immuno-Oncology 
 Consultant | Independent\, Rafet Basar | Assistant Professor | MD Anderso
 n Cancer Center\, Ramji Krishnan | Senior Vice President and Head of Tech
 nical Operations | Celularity\, Robert Igarashi &nbsp\;| Head of Discover
 y and Pre-clinical Development | Sanofi\, Sherly Mardiana | Senior Scient
 ist | Charisma Therapeutics\, Subhankar Mukhopadhyay &nbsp\;| Senior Lect
 urer and Associate professor - Innate Immunity and Regenerative Medicine 
 | &nbsp\;King's College London\n\nTime:&nbsp\;9:00 am to 4:25 pm\n
DTEND:20231019T162500
DTSTAMP:20260512T232947Z
DTSTART:20231017T090000
LOCATION:Crowne Plaza London Docklands\, an IHG Hotel\, Western Gateway\, 
 London\, Greater London\, E16 1AL\,
SEQUENCE:0
SUMMARY:The momentum of innate immune cell R and D is growing exponentiall
 y to harness innate immune responses and promote gold-standard allogeneic
  therapi...
UID:7e56b9a3-c75b-4abf-90c5-bb81d021b7d7
END:VEVENT
END:VCALENDAR